Swiss National Bank Decreases Holdings in Kenvue Inc. $KVUE

Swiss National Bank lowered its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 4.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 5,534,346 shares of the company’s stock after selling 273,700 shares during the period. Swiss National Bank’s holdings in Kenvue were worth $89,822,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the stock. Savant Capital LLC boosted its position in Kenvue by 9.1% during the 2nd quarter. Savant Capital LLC now owns 21,845 shares of the company’s stock valued at $457,000 after buying an additional 1,826 shares during the period. Vestmark Advisory Solutions Inc. raised its stake in shares of Kenvue by 115.0% during the second quarter. Vestmark Advisory Solutions Inc. now owns 47,191 shares of the company’s stock valued at $988,000 after acquiring an additional 25,245 shares during the last quarter. Wedbush Securities Inc. raised its stake in shares of Kenvue by 14.9% during the second quarter. Wedbush Securities Inc. now owns 25,221 shares of the company’s stock valued at $528,000 after acquiring an additional 3,268 shares during the last quarter. AE Wealth Management LLC grew its stake in shares of Kenvue by 47.7% in the second quarter. AE Wealth Management LLC now owns 23,428 shares of the company’s stock worth $490,000 after purchasing an additional 7,571 shares during the last quarter. Finally, Los Angeles Capital Management LLC increased its holdings in Kenvue by 18.2% during the 2nd quarter. Los Angeles Capital Management LLC now owns 144,698 shares of the company’s stock valued at $3,029,000 after purchasing an additional 22,248 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Transactions at Kenvue

In related news, Director Jeffrey C. Smith bought 3,200,000 shares of the company’s stock in a transaction on Friday, December 12th. The shares were acquired at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the acquisition, the director owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. The trade was a 13.27% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

KVUE has been the subject of a number of recent analyst reports. Citigroup upped their price target on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Barclays raised their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Friday, March 6th. UBS Group boosted their price objective on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $23.00 to $18.00 in a report on Friday, January 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $19.58.

Kenvue Price Performance

Shares of KVUE stock opened at $17.97 on Wednesday. The business’s fifty day moving average is $17.88 and its 200 day moving average is $17.35. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. The stock has a market cap of $34.43 billion, a price-to-earnings ratio of 23.33, a PEG ratio of 4.16 and a beta of 0.51. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.26 earnings per share. Research analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.